(MedPage Today) — The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday.
Generics of the SGLT2 inhibitor are indicated for glycemic control (alongside diet and…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
